Prognosis for deliveries in face presentation: a case-control study.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
10 2019
Historique:
received: 03 12 2018
accepted: 02 07 2019
pubmed: 16 7 2019
medline: 1 5 2020
entrez: 15 7 2019
Statut: ppublish

Résumé

To estimate the maternal and fetal prognosis for attempted vaginal deliveries of fetuses in face compared with vertex presentations. To evaluate the factors associated with a cesarean during labor for fetuses in face presentation. This case-control study collected all the cases of face presentation in a university hospital level-3 maternity ward between 22 and 42 weeks of gestation over a 16-year period. For each case, we selected three control cases with vertex presentations delivered the same day. Cesareans before labor were excluded. We compared 60 attempted vaginal deliveries of fetuses in face presentation with 174 of fetuses in vertex presentation. The cesarean rate during labor was more than three times higher for the face presentations (31.7 vs 9.2%, P < 0.0001). Arterial pH values and Apgar scores were similar in both sets of newborns. After logistic regression, the factors associated with a cesarean during labor were nulliparity and early diagnosis of the presentation (i.e., before 5 cm dilatation). The initial position (mentum-anterior vs. transverse or posterior) was not significantly associated with the mode of delivery. In face presentations, attempted vaginal delivery triples the cesarean risk. Nonetheless, more than two-thirds of these women give birth vaginally without any impairment of neonatal condition.

Identifiants

pubmed: 31302733
doi: 10.1007/s00404-019-05241-6
pii: 10.1007/s00404-019-05241-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

869-874

Auteurs

Emmanuelle Arsène (E)

Pôle Femme Mère Enfant, Centre Hospitalier de Calais, Boulevard des Justes, 62100, Calais, France. emmanuelle.arsene@hotmail.fr.

C Langlois (C)

Unité de Biostatistiques, MRRC, CHRU Lille, 6, rue du Professeur Laguesse, 59045, Lille cedex, France.

E Clouqueur (E)

Pôle Femme Mère Nouveau-né, Clinique d'Obstétrique, Hôpital Jeanne de Flandre, Université Nord de France, 59037, Lille cedex, France.

P Deruelle (P)

Pôle Femme Mère Nouveau-né, Clinique d'Obstétrique, Hôpital Jeanne de Flandre, Université Nord de France, 59037, Lille cedex, France.
EA 4489, Environnement périnatal et croissance, PRES Université Lille Nord de France, 59000, Lille, France.

D Subtil (D)

Pôle Femme Mère Nouveau-né, Clinique d'Obstétrique, Hôpital Jeanne de Flandre, Université Nord de France, 59037, Lille cedex, France.
EA 2694, PRES Université Lille Nord de France, 59000, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH